Reply  by Kakkos, S.K. et al.
For the VCSS to be uniformly adopted, it must prove itself
at least as good at severity measurement as other existing
validated instruments, rather than being compared with that
from which it is derived, and a better statistical tool than
correlation must be used.
Timothy Beresford, FRCS
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Reply
We thank the Editors for giving us the opportunity to respond
to Mr Beresford’s letter concerning our recently published article.
Mr Beresford focuses on the high linear correlation between the
Venous Clinical Severity Score (VCSS) and the CEAP classification
(CEAP clinical class and score). However, the stated purpose of the
study was to validate the ability of these scores in quantifying the
outcome of varicose vein surgery and to determine whether one
was more sensitive than the other.
We agree that the high correlation between the 2 scores is
expected; however, because the VCSS uses a 0 to 3 grading scheme
(0 absent, 1mild, 2moderate, and 3 severe, applied to all
10 clinical descriptors), it was supposedly better than the CEAP
clinical class. Although correlation is the appropriate statistical test
for direct comparison of two different scaled variables, we failed to
demonstrate any superiority of the VCSS in comparison with the
CEAP clinical score already in use in terms of postoperative reduc-
tion of clinical severity indicators. In addition, we used “better”
statistical tools than correlation; receiver operating characteristic
curves and measurements of the area under the curve were em-
ployed to test the ability of both scores to differentiate mild and
moderate from severe venous disease. The latter method has
obvious utility in assessing the overall discriminative validity of an
individual scoring instrument. As we think that there is no ideal
method of assessing venous outcome, we are currently using
additional scoring tools, like the Aberdeen varicose vein symptom
severity score.1
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Regarding “Fate of excluded popliteal artery
aneurysms” and “Graft patency is not the only clinical
predictor of success after exclusion and bypass of
popliteal artery aneurysms”
We were stimulated by two recent articles in the Journal of
Vascular Surgery that demonstrated continued expansion of pop-
liteal artery aneurysms following ligation, due to persistent collat-
eral perfusion.1,2 In a recent case of ours, a 77-year-old man with a
history of idiopathic thrombocytopenia (platelet count 42) pre-
sented to his general practitioner complaining of posterior knee
pain. He was found to have a lump behind the knee and was
referred for a duplex ultrasound scan. This showed a popliteal
aneurysm with a maximum diameter of 2.6 cm. The aneurysm
contained thrombus. Following platelet transfusion, he underwent
ligation of the popliteal artery aneurysm. Once the distal popliteal
artery had been ligated, the proximal popliteal artery was con-
trolled and opened. Thrombogenic foam (Spongostan; Johnson
and Johnson, Skipton, United Kingdom) was rolled up and packed
into the popliteal aneurysm in order to ensure thrombosis of the
aneurysm sac. The proximal popliteal artery was then ligated and a
reversed vein bypass was performed. The postoperative period was
uncomplicated. The patient returned three weeks after the proce-
dure and a repeat duplex ultrasound scan was performed. The
ligated aneurysm sac was noted to have no persistent flow, indicat-
ing complete exclusion of the aneurysm.
This case indicates that packing of the aneurysm sac with
thrombogenic foam appears to be an effective technique for im-
proving the exclusion of popliteal aneurysms in the early stage.
Similar material has been effective in the occlusion of side branch
endoleaks after endovascular repair of abdominal aortic aneu-
rysms.3
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